Induction of labor with a Foley catheter and the risk of subsequent preterm birth: A follow-up study of two randomized controlled trials (PROBAAT-1 and -2) by de Vaan, M.D.T. et al.

Ultrasound Obstet Gynecol 2021; 57: 292–297
Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.23117.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.
Induction of labor with Foley catheter and risk of
subsequent preterm birth: follow-up study of two
randomized controlled trials (PROBAAT-1 and -2)
M. D. T. DE VAAN1,2, D. BLEL3, K. W. M. BLOEMENKAMP4, M. JOZWIAK5,
M. L. G. TEN EIKELDER6, J. W. DE LEEUW3, M. A. OUDIJK7 , J. J. H. BAKKER7,
R. J. P. RIJNDERS1, D. N. PAPATSONIS8, M. WOISKI9, B. W. MOL10,11 and R. DE HEUS3
1Department of Obstetrics and Gynaecology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands; 2Department of Health Care
Studies, Rotterdam University of Applied Sciences, Rotterdam, The Netherlands; 3Department of Obstetrics and Gynaecology, Ikazia
Hospital, Rotterdam, The Netherlands; 4Department of Obstetrics, Division Woman and Baby, Wilhelmina Children’s Hospital Birth
Centre, University Medical Centre Utrecht, Utrecht, The Netherlands; 5Department of Gynaecologic Oncology, Erasmus Medical Centre,
Rotterdam, The Netherlands; 6Department of Obstetrics and Gynaecology, Princess Alexandra Wing, Royal Cornwall Hospital NHS Trust,
Truro, UK; 7Department of Obstetrics, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of
Amsterdam, Amsterdam, The Netherlands; 8Department of Obstetrics and Gynaecology, Amphia Hospital, Breda, The Netherlands;
9Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, The Netherlands; 10Department of Obstetrics
and Gynaecology, Monash University, Melbourne, Australia; 11Aberdeen Centre for Women’s Health Research, University of Aberdeen,
Aberdeen, UK
KEYWORDS: balloon; cervical ripening; Foley catheter; induction of labor; preterm birth
CONTRIBUTION
What are the novel findings of this work?
In women with an unripe cervix scheduled for induction
of labor, induction using a Foley catheter does not
seem to increase the risk of preterm birth in a
subsequent pregnancy, as compared with induction using
prostaglandins.
What are the clinical implications of this work?
Clinicians should not be hesitant in using a Foley catheter
for induction of labor based on the hypothetical increased
risk of preterm birth in a subsequent pregnancy, as we did
not find such an association and as it has a more optimal
neonatal safety profile compared to pharmacological
methods.
ABSTRACT
Objective To evaluate the rate of preterm birth (PTB) in
a subsequent pregnancy in women who had undergone
term induction using a Foley catheter compared with
prostaglandins.
Methods This was a follow-up study of two large
randomized controlled trials (PROBAAT-1 and
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PROBAAT-2). In the original trials, women with a
term singleton pregnancy with the fetus in cephalic
presentation and with an indication for labor induction
were randomized to receive either a 30-mL Foley
catheter or prostaglandins (vaginal prostaglandin E2 in
PROBAAT-1 and oral misoprostol in PROBAAT-2).
Data on subsequent ongoing pregnancies > 16 weeks’
gestation were collected from hospital charts from clinics
participating in this follow-up study. The main outcome
measure was preterm birth < 37 weeks’ gestation in a
subsequent pregnancy.
Results Fourteen hospitals agreed to participate in this
follow-up study. Of the 1142 eligible women, 572 had
been allocated to induction of labor using a Foley catheter
and 570 to induction of labor using prostaglandins.
Of these, 162 (14%) were lost to follow-up. In
total, 251 and 258 women had a known subsequent
pregnancy > 16 weeks’ gestation in the Foley catheter
and prostaglandin groups, respectively. There were no
differences in baseline characteristics between the groups.
The overall rate of PTB in a subsequent pregnancy was
9/251 (3.6%) in the Foley catheter group vs 10/258
(3.9%) in the prostaglandin group (relative risk (RR),
0.93; 95% CI, 0.38–2.24), and the rate of spontaneous
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd ORIGINAL PAPER
on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Balloon induction and subsequent preterm birth 293
PTB was 5/251 (2.0%) vs 5/258 (1.9%) (RR, 1.03;
95% CI, 0.30–3.51).
Conclusion In women with term singleton pregnancy,
induction of labor using a 30-mL Foley catheter is not
associated with an increased risk of PTB in a subsequent
pregnancy, as compared to induction of labor using
prostaglandins. © 2020 The Authors. Ultrasound in
Obstetrics & Gynecology published by John Wiley &
Sons Ltd on behalf of International Society of Ultrasound
in Obstetrics and Gynecology.
INTRODUCTION
Labor induction is a common obstetric procedure,
which is generally carried out when the risk of
continuing pregnancy outweighs the benefit. In the USA,
approximately one in four women is induced and, in the
last decade, the induction rate in the UK has risen to
almost 30%1,2.
Mechanical induction using a Foley catheter has gained
popularity as it has a better safety profile compared
to the conventionally used dinoprostone, reducing
the risk of neonatal morbidity while being equally
effective3,4. However, there is a hypothetical risk that
the mechanical stretch of the cervix by the balloon can
cause damage to the cervical tissue and, as a result, may
affect the risk of preterm birth (PTB) in a subsequent
pregnancy.
Cervical abnormalities, either congenital or as a result
of trauma, are a risk factor for structural cervical
weakness, which can lead to PTB. Known traumas
associated with spontaneous PTB are mechanical cervical
dilation during a gynecologic procedure and treatment
of cervical intraepithelial neoplasia5,6. It is unknown
whether a balloon catheter for labor induction has a
similar traumatizing effect on cervical integrity, which
could lead to spontaneous PTB in a subsequent pregnancy.
Studies examining the association between induction of
labor using a balloon catheter and subsequent PTB
are few and provide low-quality evidence, and no
data from randomized controlled trials (RCTs) are
available to answer the question of whether a balloon
catheter increases the risk of PTB in a subsequent
pregnancy7–9.
Our previous PROBAAT trials, two large multicenter
RCTs, showed that cervical ripening using a Foley
catheter reduced the risk of fetal distress, as compared
to cervical ripening using prostaglandin E2, whereas
there was no difference in outcome when compared to
cervical ripening using oral misoprostol. In both studies,
no difference was seen in Cesarean section rate between
the arms3,10.
The aim of this study was to evaluate the rate of PTB
in a subsequent pregnancy in women who had undergone
term induction using a Foley catheter compared to
prostaglandins, in order to assess the long-term safety
outcome of Foley catheter induction, by performing a
follow-up study of two RCTs.
METHODS
We designed a follow-up study for the PROBAAT-1
and PROBAAT-2 trials. Both studies were multicenter
RCTs, for which the full methods and results have
been published elsewhere3,10. In brief, the PROBAAT-1
trial randomized 819 women, between February 2009
and May 2010, to induction of labor using a 30-mL
Foley catheter (n = 411) or vaginal prostaglandin E2
gel (n = 408). The PROBAAT-2 trial randomized 1845
women, between July 2012 and October 2013, to
induction of labor using a 30-mL Foley catheter (n = 921)
or oral misoprostol (n = 924).
In total, 27 hospitals collaborating in the Dutch Consor-
tium for Healthcare Evaluation and Research in Obstetrics
and Gynaecology (NVOG Consortium 2.0) participated
in one or both of the PROBAAT trials. Both trials
were approved by the Central Committee on Research
Involving Human Subjects, by the ethics committee of the
Academic Medical Center, Amsterdam, The Netherlands
and by the board of directors of each participating hos-
pital and were registered with the Dutch Trial Registry
(NTR 1646 and NTR3466). The ethics committee judged
that the Research Involving Human Subjects Act did not
apply to this retrospective follow-up study and therefore
no further approval was required (date of approval 15
March 2018, ref. W18-098 #18.024). As data collection
for this follow-up study was not prespecified in the origi-
nal trial protocols, additional approval of data collection
for the purpose of this follow-up study was obtained
from the board of directors of each participating hospital.
Both PROBAAT trials included pregnant women
scheduled for induction of labor beyond 37 weeks of
gestation with a live singleton pregnancy with the fetus
in cephalic presentation, intact membranes and an
unfavorable cervix (Bishop score < 6). Women younger
than 18 years of age and those with a previous Cesarean
section, placenta previa, lethal fetal congenital anomaly
or known hypersensitivity to one of the products used for
induction were ineligible.
The pregnancy at the time of the PROBAAT trials was
considered the index pregnancy. For this follow-up study,
we included only women who had a subsequent ongoing
pregnancy beyond 16 weeks’ gestation after participation
in one of the PROBAAT trials. In the subsequent preg-
nancy, gestational age was determined by first-trimester
measurement of crown–rump length. No routine cervical
length screening was performed, and progesterone was
administered only when indicated according to local
protocol. No further exclusion criteria were specified.
Details on randomization and interventions for each
trial have been described previously3,10. In short, after
written informed consent was provided, women were
allocated randomly to induction of labor using either
a Foley catheter or prostaglandins by their attending
physician, in a 1:1 ratio, using an online program.
In both studies, women allocated to induction using
a Foley catheter had a 16-Fr or 18-Fr Foley catheter
introduced through the cervix, either digitally or using
a vaginal speculum. After the Foley catheter had passed
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the internal ostium, the balloon was filled with 30 mL
of 0.9% saline or sterile water. The external end of
the Foley catheter was taped to the inner thigh without
traction. If the Bishop score remained < 6 after 24 h, the
location of the Foley catheter was checked. When still
in correct position, the Foley catheter was either left in
place (PROBAAT-2) or replaced with a new one after
24 h (PROBAAT-1). If the Bishop score remained < 6
after 48 h, the catheter was replaced.
Women allocated to prostaglandin E2 (in PROBAAT-1)
were treated mostly with a starting dose of 1 mg
prostaglandin E2 gel, followed by 1 mg after 6 h, with
a maximum of two doses per 24 h, inserted into the
posterior vaginal fornix. An initial dose of 2 mg was
allowed in nulliparous women, as prescribed by the
manufacturer (Pfizer, New York, NY, USA). Women
allocated to oral misoprostol (in PROBAAT-2) received
50 μg capsules once every 4 h for a maximum of three
times daily.
In both trials, if the cervix was still unfavorable for
amniotomy after 48 h of treatment, women were generally
assigned a day of rest followed by another 48 h of
induction.
For this follow-up study, the databases of both studies
were combined, and study allocation was regrouped into
Foley catheter or prostaglandins. To assess eligibility,
electronic hospital records of women who participated
in one of the PROBAAT trials were searched manually
by the first and second authors. If a subsequent ongoing
pregnancy after the index pregnancy had occurred, the
required data for this study were collected. If it was not
clear if there had been a subsequent pregnancy, the case
was classified as lost to follow-up. For women who had
more than one subsequent, ongoing pregnancy, only the
first was included. Missing data are noted in the tables.
To eliminate the potential bias of an unknown history of
mechanical dilatation before a surgical abortion or PTB,
we also performed an analysis limited to women who had
two consecutive pregnancies and were primigravid during
the index pregnancy.
The main outcome of this follow-up study was PTB
< 37 weeks’ gestation in a subsequent pregnancy. Other
outcomes were spontaneous PTB < 34 and < 37 weeks’
gestation, gestational age at delivery, type of onset of
labor, mode of delivery and birth weight in a subsequent
pregnancy. For the outcome spontaneous PTB in a
subsequent pregnancy, women with iatrogenic onset of
labor (i.e. induction of labor or planned Cesarean section)
or multiple pregnancy were excluded.
Data were analyzed on an intention-to-treat basis.
Numerical variables were summarized as mean ± SD
and analyzed using the t-test if the distribution was
normal. When the distribution was skewed, they were
summarized as median with interquartile range and
analyzed using Mann–Whitney U-test. The χ2 test or
Fisher’s exact test was used to compare categorical
variables. Treatment effect was presented as relative risk
(RR) with 95% CI. A P-value of < 0.05 was considered
to indicate statistical significance. Statistical analyses were
performed using SPSS version 21.0 (IBM Corp., Armonk,
NY, USA).
RESULTS
Of the 27 hospitals that participated in the PROBAAT
trials, 14 agreed to participate in this follow-up study.
The main reason for hospitals not participating in this
follow-up study was the time-consuming process with no
funding available to compensate the hospitals for their
work. Data were collected between January 2018 and
November 2018.
During the original trial periods, 2664 women were
randomized in the PROBAAT trials, of whom 1142 were
randomized in the 14 hospitals participating in the current
study (Figure 1). The baseline characteristics of the women
Women randomized in clinics participating in follow-up study
(n = 1142)




Included in follow-up study
(n = 251)
Included in follow-up study
(n = 258)
Excluded (n = 321):
 • No subsequent pregnancy (n = 237)
 • Lost to follow-up (n = 84) 
Excluded (n = 312):
 • No subsequent pregnancy (n = 234)
 • Lost to follow-up (n = 78)
All randomized women
(n = 2664)
Figure 1 Flowchart summarizing inclusion in follow-up study of women randomized to induction of labor using Foley catheter or
prostaglandin, who had subsequent pregnancy.
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from clinics that participated in this follow-up study were
comparable to those from clinics that did not participate,
except for parity, the rate of which was slightly higher in
women in the participating clinics (Table S1).
Of the 1142 women randomized in the 14 participating
hospitals, 572 had been allocated to induction of labor
using a Foley catheter and 570 to induction of labor using
prostaglandins. Of these women, 237 (41%) and 234
(41%) did not have a subsequent, ongoing pregnancy,
and 84 (15%) and 78 (14%) were lost to follow-up,
respectively. We therefore included 251 women in the
Foley catheter group and 258 women in the prostaglandin
group (Figure 1).
Baseline characteristics of the women with a subsequent
pregnancy after the PROBAAT studies are shown in
Table 1. The groups were comparable with respect to
Table 1 Baseline characteristics of index pregnancy in 509 women
who underwent induction of labor and had subsequent pregnancy,






(n = 258) P
Parity 0.465§
Nulliparous 204 (81) 203 (79)
Parous 47 (19) 55 (21)
Body mass index
(kg/m2)
25 (22–28)† 26 (22–29)‡ 0.849¶
Ethnic origin* 0.858§
Caucasian 202/241 (84) 208/252 (83)
Non-Caucasian 40/241 (17) 43/252 (17)
Maternal age (years) 29 ± 4.5 30 ± 4.4 0.052**
Mode of delivery 0.181§
Spontaneous 164 (65) 172 (67)
Assisted vaginal 28 (11) 42 (16)
Cesarean section 59 (24) 44 (17)
Data are given as n (%), median (interquartile range), n/N (%) or
mean ± SD. Data missing for: *16 cases; †26 cases; ‡34 cases.
§Chi-square test. ¶Mann–Whitney U-test. **t-test.
age, body mass index at booking, ethnicity, parity and
mode of delivery of the index pregnancy. For women who
had an ongoing pregnancy prior to the index pregnancy,
no information was available on whether they had a
previous PTB. In the Foley catheter group, six women
had a multiple gestation in the subsequent pregnancy,
compared with five in the prostaglandin group. There
was no record of any of the included women receiving
progesterone for prevention of PTB in the subsequent
pregnancy.
No difference was found in the rate of PTB < 37 weeks’
gestation in the subsequent pregnancy between the Foley
catheter and prostaglandin groups (9/251 (3.6%) vs
10/258 (3.9%); RR, 0.93; 95% CI, 0.38–2.24). After
excluding women with iatrogenic PTB and those with
multiple pregnancy, the rate of PTB < 37 weeks in the
subsequent pregnancy remained comparable between the
groups, occurring in five women per group (2.0% vs
1.9%; RR, 1.03; 95% CI, 0.30–3.51). In the Foley
catheter group, no woman had subsequent spontaneous
PTB < 34 weeks’ gestation, compared with two women
in the prostaglandin group. No differences between the
groups were found in gestational age at delivery, type of
onset of labor, mode of delivery or neonatal birth weight
in the subsequent pregnancy (Table 2).
Per protocol analysis of women who actually received
their allocated treatment method did not affect the results.
Eleven women allocated to Foley catheter were induced
with prostaglandin, mainly because of failed placement.
Four women allocated to prostaglandin received a Foley
catheter at some point during the induction process. None
of the women who had crossover of induction methods
had PTB in the subsequent pregnancy. Post-hoc analysis
of women with two consecutive singleton pregnancies
and who were primigravid during the index pregnancy,
showed no difference in the rate of PTB < 37 weeks in
the second pregnancy between the Foley catheter and
prostaglandin groups (4/172 (2.3%) vs 2/143 (1.4%);
Table 2 Obstetric outcomes of subsequent pregnancy in 509 women who underwent induction of labor in index pregnancy, according to
randomization to Foley catheter or prostaglandins
Outcome Foley catheter (n = 251) Prostaglandin (n = 258) RR (95% CI) P
All PTB < 37 weeks 9 (3.6) 10 (3.9) 0.93 (0.38–2.24) 0.864
Spontaneous PTB < 37 weeks* 5 (2.0) 5 (1.9) 1.03 (0.30–3.51) 0.965
Spontaneous PTB < 34 weeks* 0 (0) 2 (1.0) NA 0.256**
GA at delivery (weeks) 39 + 5 (38 + 5 to 41 + 0)§ 39 + 4 (38 + 2 to 40 + 5)¶ NA 0.068††
Multiple pregnancy 6 (2.4) 5 (1.9) 1.23 (0.38–3.99) 0.726
Onset of labor†
Spontaneous 105/199 (52.8) 129/226 (57.1) 0.93 (0.78–1.10) 0.372
Induction 68/199 (34.2) 75/226 (33.2) 1.03 (0.79–1.35) 0.830
Elective Cesarean section 26/199 (13.1) 22/226 (9.7) 1.34 (0.77–2.29) 0.279
Mode of delivery‡
Spontaneous 190/242 (78.5) 199/244 (81.6) 0.96 (0.88–1.05) 0.401
Assisted vaginal 8/242 (3.3) 5/244 (2.0) 1.61 (0.54–4.86) 0.391
Cesarean section 44/242 (18.2) 40/244 (16.4) 1.11 (0.75–1.64) 0.602
Birth weight (g) 3566 ± 544† 3530 ± 511‡ NA 0.501‡‡
Data are given as n (%), median (interquartile range), n/N (%) or mean ± SD. *Including only preterm births (PTB) in singleton pregnancies
with non-iatrogenic onset of labor. Data missing for: †84 cases (52 in Foley group and 32 in prostaglandin group); ‡23 cases (nine in Foley
group and 14 in prostaglandin group); §33 cases; ¶52 cases. P-values calculated using chi-square test unless stated otherwise. **Fisher’s
exact test. ††Mann–Whitney U-test. ‡‡t-test. GA, gestational age; NA, not applicable; RR, relative risk.
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RR, 1.66; 95% CI, 0.31–8.95). Analyzing separately oral
misoprostol and prostaglandin E2 vs Foley catheter had
no effect on the observed outcome.
DISCUSSION
Main findings
The findings of this follow-up study of two RCTs
comparing mechanical induction of labor using a Foley
catheter to induction using prostaglandins, have shown
that Foley catheter is not associated with an increased risk
of PTB in the subsequent pregnancy.
Strengths and limitations
Our follow-up data were based on two large RCTs,
which minimized the risk of bias for other, sometimes
unknown, confounding factors. In these RCTs, baseline
characteristics were similar between the groups, and the
methods of induction were well-defined. Also, the fact
that, in the control arms of both studies, women were
induced by pharmacological methods, rather than having
spontaneous onset of labor, allows comparison to a rele-
vant control group, as the findings of some studies have
suggested that spontaneous term birth up to 39 weeks’
gestation could be associated with subsequent PTB8,11.
However, some undetected bias could still be present.
For instance, no information was available on whether
mechanical cervical dilation during a gynecologic pro-
cedure or treatment of cervical intraepithelial neoplasia
was performed in the period between the index preg-
nancy and subsequent pregnancy5,6. Also, no information
was available on some other known factors associated
with an increased risk of PTB, such as the interval
between the index pregnancy and subsequent pregnancy,
the incidence of PTB in a previous pregnancy before the
index pregnancy or socioeconomic factors12,13. Despite
the possible presence of confounders, the study design
makes it likely that, if present, they are equally distributed
between both groups.
In the 14 participating hospitals with 1142 included
patients, of whom 509 had a known subsequent
pregnancy, the loss-to-follow-up rate was 14%, which is
generally accepted14. Since we only had access to hospital
records, women with a low-risk subsequent pregnancy
who had only midwife-led care might have been missed.
However, the PTB rate in the lost to follow-up group is
likely to be zero, because women with preterm labor are
usually referred to the same hospital (regional referral
system).
While we included 509 women, our study could be
underpowered to detect a clinically relevant difference in
the rate of PTB between the groups. For example, given
the 3.9% rate of PTB < 37 weeks’ gestation found in the
prostaglandin group, a sample size of 1134 women would
be required to detect a two-fold increase in PTB (power,
80%; alpha error, 5%). Moreover, the sample size had to
be even higher for more clinically relevant cut-off points,
such as PTB < 34 or < 32 weeks. However, this study did
not show any trend towards a difference in the rate of
PTB between the groups, and the a-priori risk of PTB in
our population is very low.
Interpretation
Our findings are in line with those of other studies
addressing the same research question7–9. Zafran and
colleagues9 compared, in their cohort study of 366 women
with two or more known pregnancies, term induction of
labor using a balloon catheter (60-mL Foley catheter or
Cook double balloon) with term induction using vaginal
prostaglandin E2, as well as with spontaneous onset of
labor and found no difference in the rate of spontaneous
PTB < 37 weeks’ gestation in a subsequent pregnancy
(0.8% vs 0.9% vs 3.1%; P = 0.38). Sciscione and
colleagues7 compared, in their cohort study of 126 women
with two or more known pregnancies, term induction
of labor using a 30-mL Foley catheter with applied
traction to term induction using vaginal prostaglandin
E2, and also found no difference in the rate of PTB
< 37 weeks’ gestation in a subsequent pregnancy (3.2%
vs 4.7%; P = 0.53). Levine and colleagues8 also found
no association between induction of labor using a Foley
catheter, as compared with spontaneous onset of labor,
and PTB in a subsequent pregnancy in their cohort of 887
women (adjusted odds ratio, 0.41; 95% CI, 0.15–1.12).
Although all of the above studies addressed the same
research question, heterogeneity exists between studies
with regard to the balloon volume and whether or
not traction was applied. In our study, a 30-mL Foley
catheter was placed above the internal ostium and used
without traction. Looking at contributing factors for
cervical weakness, it is reasonable to believe that using
a larger balloon volume or a double Cook balloon, in
which an 80-mL balloon is placed above and below
the internal ostium, or applying traction, could have
the potential to cause more cervical tissue damage and
therefore have more effect on cervical integrity. However,
such an association was not found by researchers who
used these methods7,9. High-volume balloons, double
balloons or applying traction are used to expedite labor.
However, not all of these strategies have been proven
to shorten this process. Although a double balloon or
applying traction may shorten the period from start of
induction to expulsion of the balloon, these approaches
do not increase the number of vaginal deliveries within
24 h and have the disadvantage of causing more pain
during the induction process15–18.
In the present follow-up study, the PTB rate was 3.7%,
which is low in comparison to the national PTB rate of
7.2% in The Netherlands19. This could be explained by
the fact that women in this study had induction of labor
at term in their index pregnancy and had a relatively
low-risk pregnancy, which could influence the baseline
risk of PTB in this specific population. This hypothesis
is also supported by the comparable numbers of PTB in
relatively similar populations. Baer and colleagues20, in
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a Californian cohort of 133 662 women, found a PTB
rate of 3.2% after a previous term birth between 39 and
42 weeks of gestation. Furthermore, Zafran et al.9 and
Sciscione and colleagues7 found relatively low numbers
of PTB in the subsequent pregnancy after term induction
using a Foley catheter (0.5% (spontaneous PTB) and
3.2%, respectively). Levine and colleagues8 are the only
ones to report a PTB rate of 10% in a subsequent
pregnancy after term labor induction. However, the
spontaneous PTB rate was 6%, while in women induced
with a Foley catheter, the spontaneous PTB rate was 4%.
Conclusion
In women with an unripe cervix scheduled for induction
of labor, induction using a Foley catheter does not seem
to increase the risk of PTB in a subsequent pregnancy, as
compared with induction using prostaglandins.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1 Baseline characteristics of women randomized to induction of labor using Foley catheter or
prostaglandin, according to whether they were randomized in clinic that participated in follow-up study
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